SelectQuote, Inc. (NYSE: SLQT) announced the formation of a Healthcare Advisory Board to help the company strengthen the mission and clinical strategy of Population Health. This group of world-class experts will advise Population Health on ways to empower, engage and educate consumers on healthcare solutions and benefits, equipping them to lead healthier lives through improved health outcomes while reducing costs for patients and the healthcare system. This group of world-renowned leaders brings comprehensive healthcare expertise from the pharmaceutical, health IT, payer, provider, and regulatory market segments and will provide important insight and expertise to help shape continuing innovation and growth at Population Health.
“We are excited to welcome such distinguished industry leaders as the inaugural members of our Healthcare Advisory Board. The development of our Healthcare Advisory Board is the next step in expanding Population Health and the services we offer through this platform,” said Bob Grant, SelectQuote President. “The Advisory Board consists of highly sought after members of the healthcare community who can provide insights and recommendations on Population Health’s strategy, objectives and partnerships. These deeply experienced individuals bring unparalleled expertise in healthcare, and we are excited they see that our vision for Population Health is both achievable and an important step forward for the future of healthcare.”
The Advisory Board will be led by SelectQuote Board members Kavita Patel, MD and Earl “Trace” Devanny. Advisory Board members include:
Basit Chaudhry, MD is an internal medicine physician and medical technologist who founded Tuple Health in 2013. His expertise spans healthcare payment, clinical service redesign, and the use of data analytics to improve clinical and financial performance in healthcare.
Alan Muney, MD is currently an external advisor to Bain & Company, and a Senior Advisor for Pritzker Private Capital, NEA and Arsenal Capital Partners. From 2010 to 2018, he was the Executive Vice President and Chief Medical Officer for Cigna, leading the company’s health management and network contracting activities.
Joe Grogan is a former Assistant to the President, Director of the Domestic Policy Council and Associate Director, Health Programs for the Office of Management and Budget. He is currently a Fellow with the USC Schaeffer Center. He has served at senior management roles at Amgen, Inc., and Gilead Sciences, Inc., and he has an extensive background working with the FDA on regulatory, legislative and policy initiatives.
Rebekah Gee, MD is the President and Founder of Nest Health and CEO of Healthcare Services for LSU Health. She formerly served as Secretary of the Louisiana Department of Health, the state’s largest agency. She is a policy expert and is widely published in health services research, and has served in numerous additional state and national policy roles.
Dr. Patel is currently a Fellow with the Brookings Institute and served in the Obama Administration as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement. She is also an advisor to the Bipartisan Policy Center and a member of Health and Human Services Physician Focused Payment Model Technical Advisory Committee.
Devanny is the former CEO of Tract Manager, a provider of healthcare strategic sourcing and compliance application suites. From 2014 to 2016, he served as President of Nuance Communications’ healthcare business. He has also led healthcare company Trizetto Corporation and health information technology company Cerner Corporation.
"The Advisory Board’s expertise spans payers, policy, technology, providers and patients. It is an incredible group that will help make a meaningful impact on the Population Health work of SelectQuote," said Dr. Patel. "I look forward to working with the Advisory Board to make an impactful difference in how we view healthcare."
The Advisory Board will report directly to a newly formed standing committee of SelectQuote’s Board of Directors.
Forward Looking Statement
This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.
Our actual results to differ materially from those indicated in these forward-looking statements due to a number of important factors, including, but not limited to, the following: the ultimate duration and impact of the ongoing COVID-19 pandemic; our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and claims, including IP litigation; our existing and future indebtedness; developments with respect to LIBOR; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers’ approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; and failure to market and sell Medicare plans effectively or in compliance with laws. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled “Risk Factors” in our most recent Annual Report on Form 10-K that we have filed with the Securities and Exchange Commission, and our subsequent filings with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.
About SelectQuote:
Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health and property. SelectQuote pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin the company’s success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. SelectQuote has three core business lines: SelectQuote Senior, SelectQuote Life and SelectQuote Auto and Home. SelectQuote Senior, the largest and fastest-growing business, serves the needs of a demographic that sees 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. In 2021, SelectQuote expanded its business with the addition of Population Health, a healthcare services company, and SelectRx, a specialty medication management pharmacy.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220301005393/en/